Immune hyperactivation and progressive loss of CD4 + T cells, including regulatory T (Treg) cells, are associated with human immunodeficiency virus type 1 (HIV-1) disease progression [1] . CD4 + CD25 + Treg cells play a critical role in modulating the immunopathogenesis of a number of diseases, including autoimmune and infectious diseases [2] . In HIV-infected patients or simian immunodeficiency virus-infected rhesus macaques, Treg cells are accumulated and infected in acutely infected hosts, but numbers are gradually reduced during chronic pathogenic infection [3] . However, the role of Treg cells in HIV-1 infection and pathogenesis is not clearly defined, because of a lack of a robust model. We have recently reported that functional Treg cells are developed in all lymphoid organs in humanized mice. In addition, Treg cells are preferentially infected, and depletion of Treg cells before HIV-1 infection in humanized mice leads to an elevated immune response and reduced HIV-1 replication [4] . Liver disease has become a leading cause of non-AIDSrelated mortality because HIV-infected patients continue to live longer because of successful antiretroviral therapy. HIV-1-infected patients are often infected with hepatitis C virus (HCV) because the pathogens share transmission routes [5] . HIV/HCV coinfection leads to accelerated hepatic fibrosis and to higher rates of liver failure and death, compared with HCV monoinfection [5] . Furthermore, HIV-1-infected patients have a significant risk of liver fibrosis, even without hepatitis virus coinfection [6] . Both virologic and immunologic mechanisms have been postulated [5] . However, the role of Treg cells in hepatic immunopathology during HIV-1 infection with or without HCV coinfection is unclear. We hypothesized that Treg cells played a role in modulating liver diseases during HIV-1 infection. We determined the role of Treg cells in liver fibrosis during HIV-1 infection in vivo, using a humanized mouse model.
METHODS

Construction of Humanized Mice
Approval for animal work was obtained from the University of North Carolina Institutional Animal and Use Committee.
Rag2
−/− IL-2Rγ −/− or NOD-scid IL-2Rγ −/− mice were used to create humanized mice. We constructed humanized mice as previously reported [4] . In brief, human CD34 + hematopoietic stem cells were isolated from liver tissue of human fetuses with a gestational age of 16-18 weeks. Tissue was first perfused with liver perfusion medium then with liver-digest medium (Invitrogen, Frederick, MD). The cell suspension was filtered through a 70-µm cell strainer (BD Falcon, Lincoln Park, NJ) and centrifuged at 150 g for 5 minutes to collect mononuclear cells. Cell viability, measured using Guava Easy Cyte (Millipore, Billerica, MA), generally exceeded 90%. After selection with the CD34 magnetic-activated cell sorting kit (Miltenyi Biotech, Gladbach, Germany), the purity of CD34 + cells was >95%. HBSS-injected humanized mice were used as controls. Either denileukin diftitox-injected or HBSS-injected humanized mice were retro-orbitally infected with HIV-R3A stocks which is a CCR5/CXCR4 dual tropic and highly pathogenic virus (1 ng p24/mouse in 50µL). Humanized mice infected with mock stocks were included as control groups. At the time of euthanization (20 days after infection), blood, spleen, and liver were harvested, and cell numbers were counted by Guava Easy Cyte.
Flow Cytometry Analysis
At the time of euthanization, lymphocytes were isolated from the liver tissue by the ACK lysis method. Lymphocytes were stained with anti-human CD45, CD25, CD4, CD8, and CD3 (Biolegend, San Diego, CA); mouse CD45 (Invitrogen); and the Live/Dead Fixable dead cell stain kit (Invitrogen). The Cytofix/ Cytoperm kit (BD Bioscience, San Jose, CA) and anti-HIV-1 p24 antibody (Beckman Coulter, Fullerton, CA) were used for intracellular p24 staining. Stained cells were fixed and analyzed by CyAn ADP (Dako, Glostrup, Denmark).
Immunohistochemistry Staining and Area Quantification
Paraffin-embedded sections of livers from humanized mice were stained with hematoxylin and eosin, Sirius red/fast green, or primary antibodies. After the incubation of sections with primary antibodies, primary antibodies were detected with Rat and Mouse Double Stain kit (Biocare Medical, Concord, CA). The slides were developed with the Betazoid DAB chromogen kit or the Vulcan Red chromogen kit 2 (Biocare medical). Slides were observed using an Eclipse E600 microscopy system (Nikon, Garden City, NY) with a 10× or 20× nonoil objective and a 10× ocular lens. Images were captured using OmniVid microscope camera (LW Scientific, Lawrenceville, GA 
Alanine Transaminase (ALT) and Hyaluronic Acid Levels in Plasma
Blood specimens from humanized mice were obtained at indicated time points, using ethylenediaminetetraacetic acid as an anticoagulant. Plasma was then prepared by centrifugation. Plasma ALT and hyaluronic acid levels were measured by the ALT Color Endpoint Assay kit (Bioo Scientific, Austin, TX) and the hyaluronic acid ELISA kit (Echelon, Salt Lake City, UT), respectively.
Gene Expression Analysis
Liver tissue was harvested from each humanized mouse and stored using RNAlater (Qiagen, Germantown, MD). Total RNA was extracted from liver tissue, using the RNeasy Plus Mini Kit (Qiagen). Complementary DNA was reverse transcribed using Super Script III reverse transcriptase (Invitrogen). Human-and mouse-specific tissue inhibitor of metalloproteinase 1 (TIMP-1) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) real-time quantitative polymerase chain reaction (qPCR) primers were designed and described previously [7] . The real-time qPCR primers for human interleukin 6 (IL-6), tumor necrosis factor α (TNF-α), monocyte chemotactic protein 1 (MCP-1), macrophage inflammatory protein 1α (MIP-1α), and α-smooth muscle actin (SMA) were previously reported [8, 9] . Gene expression was examined using Thermo Scientific SYBR green real-time PCR reagents (Thermo Scientific, Waltham, MA). GAPDH was used to normalize messenger RNA (mRNA) expression. mRNA expression was shown by either fold induction or arbitrary relative expression.
Statistical Analysis
Unpaired 2-tailed Student t tests and 1-way analysis of variance with the Bonferroni multiple comparison test were performed using GraphPad Prism (GraphPad Software, San Diego, CA). A P value of < .05 was considered statistically significant. All data were reported as mean ± SD.
RESULTS
We used the interleukin 2-toxin fusion protein denileukin diftitox to deplete CD4 + CD25 hi Treg cells from humanized mice.
A Figure 1 and the article by Jiang et al [4] ). To define the role of Treg cells in hepatitis during HIV-1 infection, we quantified liver proinflammatory cytokine and chemokine expression. We found that expression of the human proinflammatory cytokines IL-6 and TNF-α was increased in the denileukin diftitox group. Their expression was further increased in the HIV-1 plus denileukin diftitox group ( Figure 1A and 1B) . Interestingly, expression of the human inflammatory chemokines MCP-1 and MIP-1α was highly upregulated by denileukin diftitox alone in the liver ( Figure 1C and 1D) , and HIV-1 infection showed no significant further induction.
To detect leukocyte infiltration in the liver, we stained liver sections with hematoxylin and eosin and human leukocyte markers. We detected significant leukocyte infiltration only in the liver of the HIV-1 plus denileukin diftitox group ( Figure 1E and 1H). The infiltrated leukocytes included human CD45 + cells, CD3 + T cells, and CD68 + macrophages (CD45, CD3, and CD68; Figure 1E ). They also included Ki-67 + proliferating cells (Ki-67; Figure 1E ) and p24 + HIV-infected cells (Supplementary Figure 2A) . Consistently, infiltrated human leukocyte numbers were significantly increased only in the HIV-1 plus denileukin diftitox group ( Figure 1F and Supplementary Figure 3A and 2B). These data suggested that Treg cell depletion and HIV-1 infection cooperatively induced inflammatory cytokines/chemokines and hepatitis in the liver. To detect liver injury associated with hepatitis, we measured ALT levels in the plasma. ALT levels were significantly elevated only in mice from HIV-1 plus denileukin diftitox group 20 days after infection (Figure 2A ). These data suggest that Treg cells prevent HIV-1-induced liver damage in humanized mice. We further measured the plasma hyaluronic acid level, which is a marker of hepatic injury and fibrosis. Similar to ALT levels, no significant increase of plasma hyaluronic acid levels was found in recipients of mock stock, mock stock plus denileukin diftitox, and HIV-1. However, we detected significantly elevated hyaluronic acid levels only in the HIV-1 plus denileukin diftitox group 20 days after infection ( Figure 2B ). Consistent with the elevated liver inflammation and injury, we observed that livers from mice in the HIV-1 plus denileukin diftitox group showed significant pathology ( Figure 2C ).
To further investigate the liver immunopathogenesis, we stained liver sections with Sirius red/fast green. We observed significant collagen deposition in the parenchymal area only in the livers from mice in the HIV-1 plus denileukin diftitox group ( Figure 2D and 2E ) . Activation of hepatic stellate cell and their transition to myofibroblast is a key step for liver fibrosis development, and activated hepatic stellate cells (or myofibroblasts) express glial fibrillary acidic protein (GFAP) [10] and α-SMA. To determine hepatic stellate cell activation in the liver, we stained liver sections with antibodies specific to human GFAP and α-SMA. We found that GFAP and α-SMA expression was clearly associated with collagen deposition ( Figure 2D and 2E and data not shown) . We further quantified liver fibrosis by measuring expression of TIMP-1 in the liver. Expression of human (but not mouse) TIMP-1 mRNA in the liver of HIV-1 plus denileukin diftitox group was significantly induced ( Figure 2F ). Therefore, depletion of Treg cells and HIV-1 infection cooperatively lead to liver inflammation and fibrosis.
DISCUSSION
Our findings indicate that Treg cells prevent HIV-1-induced liver fibrosis associated with hepatic stellate cell activation, hepatitis, and liver injury. Consistent with recent reports [11] , MCP-1 is likely to play an important role in the fibrogenic process initiated by inflammation in HIV-1-induced liver fibrosis. MCP-1 may serve as both fibrogenic mediator and chemoattractant for leukocytes to the liver. Moreover, a low Treg frequency was observed in HCV-infected patients, compared with healthy controls [12] . Treg cell depletion is likely to induce inflammation and fibrosis in virus-induced liver fibrosis (Supplementary Figure 3C and 3D). However, Treg cells were reported to be infiltrated in HCV-infected liver [12] . It would be interesting to determine the role of intrahepatic Treg cells in liver fibrosis. Figure 2A) . Both HIV-1 and human leukocytes can promote human hepatic stellate cell activation [5, 13, 14] . HIV-1 infection and liver inflammation by Treg cell depletion cooperatively induces liver fibrosis. It will be of great interest to elucidate the molecular mechanism of Treg cells in protecting liver fibrosis during HIV-1 infection in future experiments. The origin of the human hepatic stellate cells or myofibroblasts [13] in the humanized mouse is currently not clear. Bone marrow-derived cells can contribute significantly to myofibroblast populations during induction of liver fibrosis and cirrhosis [15] . Transdifferentiation of myofibroblasts from bone marrow-derived cells may be induced by HIV-1 infection and Treg cell depletion. Alternatively, these cells may be derived from human liver stem or progenitor cells in the CD34-enriched progenitor populations isolated from fetal livers [13] .
Humanized mouse models still have some limitations in the study of liver disease in human hepatic virus infection, including low human cell engraftment and reduced immune activity. In addition, R3A is a highly pathogenic HIV-1 strain. Thus, it is important to confirm the findings with less pathogenic HIV-1 isolates in the future. We have recently developed a novel humanized mouse model that has a human immune system and human hepatic cells [7] . Our findings provide new insight linking Treg cells and liver immunopathogenesis during HIV-1 infection. With this model, we will be able to test the role of 
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